NBIX
Neurocrine Biosciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$155.64
−1.71%Forward multiples
Based on analyst estimates
- P/E forward
- 18.42x
- P/E 2026E
- 22.22x
- P/E 2027E
- 16.03x
- P/E 2028E
- 12.50x
- P/S forward
- 3.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.08x
- PEG TTM
- 1.12x
- Price / book
- 4.28x
- Price / sales
- 4.69x
- Price / cash flow
- 17.62x
Enterprise value
- Enterprise value
- $15.8B
- EV / sales
- 4.69x
- EV / EBITDA
- 17.25x
- EV / EBIT
- 20.07x
- Market cap
- $15.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026